Building a ‘Three-Pronged Governance’ Model for Cross-Border Data Compliance in the Biomedical Industry under the Dual Circulation Pattern

Authors

  • Gang Xue

DOI:

https://doi.org/10.54097/44c7mx79

Keywords:

Biopharmaceutical data, Cross-border flow, Tripartite governance, Federated learning, Compliance framework

Abstract

The development of the digital economy has accelerated the global flow of biomedical data, making cross-border governance a critical issue. This study innovatively constructs a ‘regulation-enterprise-technology’ tripartite dynamic balance governance model and proposes a systematic solution combining data classification and categorisation management, standardised compliance frameworks, and federated learning technologies. The study is based on the pilot practice in Shanghai Lingang, verifying the model's application value in reducing compliance costs and enhancing innovation efficiency. The research findings offer new insights into resolving the contradiction between data sovereignty security and global data flow, driving the digital transformation and innovative development of the biopharmaceutical industry.

Downloads

Download data is not yet available.

References

[1] Song J, Gong Z. The power of gaps: Multilayer mechanisms and source tracing of complex dynamics in higher-order networks [J]. Applied Mathematics and Computation, 2026, 508.

[2] Wu J, Jiang L, Li C. Optimization of Rural Governance Structure under the Development of New Agricultural Management Entities [J]. Proceedings of Business and Economic Studies, 2023, 6(6):55-62.

[3] Zhou Y, Wang X, Zhang D, et al. Precision‐Guided Stealth Missiles in Biomedicine: Biological Carrier‐Mediated Nanomedicine Hitchhiking Strategy [J]. Advanced Science, 2025, 12(21).

[4] Andrey V, Koshevaya E, Mstislav M, et al. Piezoelectric PVDF and its copolymers in biomedicine: innovations and applications [J]. Biomaterials Science, 2024, 12.

[5] Frazier‐Bowers, S. A, Allareddy V, Rengasamyvenugopalan S, et al. Preface to the 9th Biennial COAST Conference: Harnessing Technology and Biomedicine for Personalized Orthodontics [J]. Orthodontics & Craniofacial Research, 2023, 26.

[6] Mangini M, Rea I, E.LonardoE. De TommasiD. Delle CaveL.De StefanoA.C. De Luca. Diatom-based SERS substrates for applications in biomedicine [J]. Il Nuovo Cimento della Societa Italiana di Fisica, C. Geophysics and space physics, 2023, 46C(4):132-1-132-4.

[7] Chen H, Varatharajah Y, Stewart de Ramirez S, Arnold P, Frankenberger C, Hota B, Iyer R. A Retrospective Longitudinal Study of COVID-19 as Seen by a Large Urban Hospital in Chicago [EB/OL]. medRxiv, 2020-11-29.

[8] Wang Y. Efficient Adverse Event Forecasting in Clinical Trials via Transformer-Augmented Survival Analysis [J]. 2025.

[9] Wang Y. Construction of a Clinical Trial Data Anomaly Detection and Risk Warning System based on Knowledge Graph [C]//Forum on Research and Innovation Management. 2025, 3(6).

[10] Qi R. DecisionFlow for SMEs: A Lightweight Visual Framework for Multi-Task Joint Prediction and Anomaly Detection [J]. 2025.

Downloads

Published

09-09-2025

Issue

Section

Articles

How to Cite

Xue, G. (2025). Building a ‘Three-Pronged Governance’ Model for Cross-Border Data Compliance in the Biomedical Industry under the Dual Circulation Pattern. Frontiers in Business, Economics and Management, 20(3), 89-92. https://doi.org/10.54097/44c7mx79